Literature DB >> 21700098

Oval capsulorhexis for phacoemulsification in posterior polar cataract with preexisting posterior capsule rupture.

Kiranjit Singh1, Vikas Mittal, Harmit Kaur.   

Abstract

We describe use of an oval capsulorhexis rather than the conventional circular capsulorhexis for phacoemulsification in posterior polar cataract with preexisting posterior capsule rupture. An oval capsulorhexis minimizes the turbulence in the capsular bag by increasing the area available for efflux of fluid. It also enables end-to-end nuclear sculpting, removal of the nuclear fragment from the bag, intraocular lens (IOL) implantation, and vitrectomy without stretching the capsular bag. The smaller axis of the oval capsulorhexis facilitates optic capture of a sulcus-fixated IOL. The oval capsulorhexis can be used safely for phacoemulsification of all grades of nuclear sclerosis in posterior polar cataract with preexisting posterior capsule rupture.
Copyright © 2011 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21700098     DOI: 10.1016/j.jcrs.2011.04.017

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  3 in total

1.  Anterior segment optical coherence tomography for demonstrating posterior capsular rent in posterior polar cataract.

Authors:  George D Kymionis; Vasilios F Diakonis; Dimitrios A Liakopoulos; Konstantinos I Tsoulnaras; Nektarios E Klados; Ioannis G Pallikaris
Journal:  Clin Ophthalmol       Date:  2014-01-10

Review 2.  Managing the posterior polar cataract: An update.

Authors:  Abhay R Vasavada; Vaishali A Vasavada
Journal:  Indian J Ophthalmol       Date:  2017-12       Impact factor: 1.848

3.  Phacoemulsification with hydrodelineation and OVD-assisted hydrodissection in posterior polar cataract.

Authors:  Xia Hua; Yongxiao Dong; Jianying Du; Jin Yang; Xiaoyong Yuan
Journal:  BMC Ophthalmol       Date:  2018-07-09       Impact factor: 2.209

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.